RECITALSState of Texas • September 11th, 2015 • Mirna Therapeutics, Inc. • Pharmaceutical preparations • Texas
performed or services delivered and comply with all federal and state laws regarding the conduct of the research or service.
FUNDING AGREEMENTState of Texas • March 30th, 2020
This INTERLOCAL COOPERATION AGREEMENT (“Agreement”) is executed by and between HILL COUNTRY COMMUNITY MINISTRIES, 1005 Lacy Drive, Leander, Texas, hereinafter referred to as “HCCM”, and the CITY OF LEANDER, Texas, a home rule municipal corporation organized under the laws of the State of Texas, hereinafter referred to as the “City”, P.O. Box 319, Leander, Texas 78646, acting by and through their duly authorized representatives.
RECITALSState of Texas • June 16th, 2015 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
Section C1.04 Conduct of Research or Service Provided. RECIPIENT understands that the Project must be conducted with full consideration for the ethical and medical implications of the research performed or services delivered and comply with all federal and state laws regarding the conduct of the research or service.
INTERLOCAL COOPERATION AGREEMENT FOR LAW-ENFORCEMENT SERVICESState of Texas • August 3rd, 2017 • Texas
By their authority under the Interlocal Cooperation Act, Texas Government Code, chapter 791, Collin County and the Blue Ridge Independent School District enter this Interlocal Cooperation Agreement for Law-Enforcement Services. Through the Sheriff’s Office, Collin County will provide a licensed peace officer as a School Resource Officer (SRO) for a dedicated, full-time assignment in Blue Ridge ISD. Blue Ridge ISD will reimburse the County for the SRO’s compensation and certain expenses.
STATE OF TEXAS COUNTY OF TRAVISState of Texas • February 13th, 2019 • Molecular Templates, Inc. • Pharmaceutical preparations • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and Molecular Templates, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
